Back
NVIDIA Vs. Akero Therapeutics Industry Stock Comparison
Sell
44
NVDA
NVIDIA
Last Price:
$120.10
Seasonality Move:
14.93%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$54.05
Seasonality Move:
-13.54%
Sell
44
NVIDIA (NVDA)
is a Sell
Is NVIDIA a Buy, Sell or Hold?
-
NVDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.36. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
NVDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.68 | Sell |
Relative Strength Index (14 RSI): | 41.59 | Sell |
Chaikin Money Flow: | 347341178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (129.68 - 144.16) | Sell |
Bollinger Bands (100): | (122.86 - 144.46) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.46 | Buy |
Relative Strength Index (14 RSI): | 86.44 | Buy |
Chaikin Money Flow: | -1207308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.44 - 40.6) | Buy |
Bollinger Bands (100): | (24.53 - 35.29) | Buy |
NVDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 134.19 | Sell |
20-day SMA: | 136.43 | Sell |
50-day SMA: | 137.72 | Sell |
200-day SMA: | 122.08 | Buy |
8-day EMA: | 130.59 | Sell |
20-day EMA: | 134.5 | Sell |
50-day EMA: | 135.95 | Sell |
200-day EMA: | 119.73 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.44 | Buy |
20-day SMA: | 31.04 | Buy |
50-day SMA: | 30.48 | Buy |
200-day SMA: | 26.55 | Buy |
8-day EMA: | 43.24 | Buy |
20-day EMA: | 35.07 | Buy |
50-day EMA: | 31.47 | Buy |
200-day EMA: | 28.51 | Buy |
NVIDIA Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.11 per share, an increase this year of $1.71 per share, and an increase next year of $1.49 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $0.02 per share.
NVIDIA Technical Analysis
Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |